Mark Prygocki is the current director at Verrica Pharma. Mark has also worked as the director, chairman, and audit committee of the board of directors at Revance Therapeutics and as a client at Cushman & Wakefield. Mark Prygocki has experience in expanding patient choice in a market and in overseeing the creation of thousands of combinations of customer-designed doughnuts. Mark plans to open approximately 15 Fractured Prune Doughnut stores in Arizona.
Mark Prygocki has a Bachelor of Science in Accounting from Pace University.